Progestin‐associated meningiomas can be managed by discontinuing treatment

Takeaway

  • The number of progestin‐associated meningiomas in women has increased over the past two decades; discontinuing treatment is a safe and effective way to treat these tumors.

Why this matters

    These novel findings highlight the need for more standardized data collection of essential information regarding progestin treatments. Magnetic resonance imaging should be readily accessible to women using progestin to facilitate screening, rapid identification, and management of meningiomas.